← Leaderboards
Juan Carlos Garcia Marvizon
University Of California Los Angeles
$2,931,076
Attributed
$3,615,067
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $277.2K · FY2005–18$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,615,067 · 2
VA$0 · 2
By mechanism
R01$3,615,067 · 2
I01$0 · 2
Top collaborators
- James A Mcroberts5 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Niall P Murphy$1,659,641
- Yvette France Tache$17,660,715
- Christopher J Evans$13,104,202
- Xiangdong William Yang$28,254,046
- Michael S Fanselow$16,502,664
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainNeuronsOpioid ReceptorDorsal HornReceptor InternalizationSpinal CordNociceptionChronic PainRattusLesionPosterior Horn CellsNerveNeuraxisPainful NeuropathyAffectPhosphorylationSpontaneous PainUnited StatesReceptorMediatingOpioidPharmaceutical PreparationsN-Methyl-D-Aspartate ReceptorsSignal Pathway
Grant awards (22)
Latent Sensitization and Neuropathic Pain$0
I01 · FY2018 · VA · contact PI
Latent Sensitization and Neuropathic Pain$0
I01 · FY2017 · VA · contact PI
NMDA Receptors in Primary Afferents$274,428
R01 · FY2016 · DA · contact PI
Latent Sensitization and Neuropathic Pain$0
I01 · FY2016 · VA · contact PI
Latent Sensitization and Neuropathic Pain$0
I01 · FY2016 · VA · contact PI
NMDA Receptors in Primary Afferents$273,042
R01 · FY2015 · DA · contact PI
NMDA Receptors in Primary Afferents$277,200
R01 · FY2014 · DA · contact PI
Neurotransmitter control of substance P release in the spinal cord$0
I01 · FY2014 · VA · contact PI
Neurotransmitter control of substance P release in the spinal cord$0
I01 · FY2014 · VA · contact PI
Neurotransmitter control of substance P release in the spinal cord$0
I01 · FY2014 · VA · contact PI
NMDA Receptors in Primary Afferents$266,112
R01 · FY2013 · DA · contact PI
NMDA Receptors in Primary Afferents$277,200
R01 · FY2012 · DA · contact PI
Neurotransmitter control of substance P release in the spinal cord$0
I01 · FY2012 · VA · contact PI
Spinal Opioid Release in Nociception$234,162
R01 · FY2008 · DA · contact PI
Spinal Opioid Release in Nociception$238,941
R01 · FY2007 · DA · contact PI
Spinal Opioid Release in Nociception$238,360
R01 · FY2006 · DA · contact PI
Spinal Neurokinin and Opioid Release in Nociception$212,492
R01 · FY2005 · DA
SPINAL NEUROKININ AND OPIOID RELEASE IN NOCICEPTION$261,100
R01 · FY2004 · DA
SPINAL NEUROKININ AND OPIOID RELEASE IN NOCICEPTION$261,100
R01 · FY2003 · DA
SPINAL NEUROKININ AND OPIOID RELEASE IN NOCICEPTION$261,100
R01 · FY2002 · DA
SPINAL NEUROKININ AND OPIOID RELEASE IN NOCICEPTION$261,920
R01 · FY2001 · DA
SPINAL NEUROKININ AND OPIOID RELEASE IN NOCICEPTION$277,910
R01 · FY2000 · DA